With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
PARTNER, RIFLE, TWENTE, transcatheter valves, novel DES, and renal denervation — Drs. Worthley and Meredith give their take on the hot topics for the interventionalist.
When is it appropriate to revascularize patients with stable ischemic heart disease? Dr. King walks through 2 typical cases outlining the data behind his decision-making.
Antiplatelet options in ACS are expanding across the globe. Dr. Abizaid from Brazil and Dr. Gaxiola from Mexico discuss 2 ACS cases and the data behind their decision-making.
Our expert panelists Drs. Leon and Di Mario discuss 2 complex cases presented by Drs. Byrne and Lee with challenging questions for the audience along the way. Take the challenge and see your peers' responses.
So long Cypher. Hello Resolute and Promus Element. What is your response to recent developments in the world of DES? Will PRECOMBAT or ISAR-CABG change your practice? Answer our polling questions and learn what your colleagues do.
Surgeon Dr. Puskas and interventionalist Dr. Fox discuss bridging strategies and thienopyridine discontinuation as well as the ACC late-breaking STICH and RAPS trials.
After the groundbreaking PARTNER Cohort B presentation, what's next for transcatheter valves? Drs. Popma and Kodali discuss these data and other upcoming trials.